Evidence map›Paper›PMID 38094158›Full record

ArticleFASEB bioAdvances2023

Increased lethality of respiratory infection by

Kelley L Colvin, Robert J Elliott, Desiree M Goodman, Julie Harral, Edward G Barrett, Michael E Yeager

Open access · goldAbstract read
In one paragraph

Article in FASEB bioAdvances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Kelley L ColvinDepartment of Bioengineering University of Colorado Aurora Colorado USA.
Robert J ElliottDepartment of Bioengineering University of Colorado Aurora Colorado USA.
Desiree M GoodmanLinda Crnic Institute for Down Syndrome, University of Colorado Aurora Colorado USA.
Julie HarralUniversity of Colorado Denver Health Sciences Aurora Colorado USA.
Edward G BarrettLovelace Biomedical Research Institute Albuquerque New Mexico USA.
Michael E YeagerDepartment of Bioengineering University of Colorado Aurora Colorado USA.ORCID https://orcid.org/0000-0003-4306-4162
University of Colorado Hospital · USLovelace Respiratory Research Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: We sought to investigate whether the Dp16 mouse model of Down syndrome (DS) is more susceptible to severe and lethal respiratory tract infection by Study Design: We infected controls and Dp16 mice with Results: We found that the Dp16 mouse model of DS displayed significantly higher susceptibility to lethal respiratory infection with Conclusions: Increased susceptibility to severe respiratory tract infection with

Identifiers

PMID38094158
PMCPMC10714064
OpenAlexW4388100496

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.